CONCORD DRUGS
Back to Cashflow Statement
|
CONCORD DRUGS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-0.02 Cr | ₹0.07 Cr | ₹0.02 Cr | ₹0.01 Cr |
What is the latest Net Cash Inflow / Outflow ratio of CONCORD DRUGS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-0.02 Cr |
| Mar2024 | ₹0.07 Cr |
| Mar2023 | ₹0.02 Cr |
| Mar2022 | ₹0.01 Cr |
How is Net Cash Inflow / Outflow of CONCORD DRUGS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.02 Cr | Negative | |
| Mar2024 | ₹0.07 Cr | 204.55 | |
| Mar2023 | ₹0.02 Cr | 144.44 | |
| Mar2022 | ₹0.01 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹94.4 Cr | 2% | -7.3% | 3.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | 2% |
-7.3% |
3.6% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses